Invited Speakers:
|
|
- Jörg Eder, Executive Director, Novartis Institute for Biomedical Research, - Chas Bountra, Professor of Translational Medicine in the Nuffield Department of Clinical Medicine, and Chief Scientist, Structural Genomics Consortium - Jinghai (Jim) Xu, Executive Director, Merck - Jutta Heim, CEO, Evolva - Ingo Mügge, Senior Research Fellow, Boehringer Ingelheim - Stevan Djuric, Senior Director Medicinal Chemistry Technologies, Abbott - Sara Colombetti, Group leader In Vivo Models, Roche - Steven England, Director, Head of Future Therapeutics & Technologies, AbbVie - Nicolas Fischer, Head of Research, Novimmune SA - Matthias Frech, Head of Molecular Interactions & Biophysics, Merck - Jutta Helm, CEO, Evolva - Rod Hubbard, Senior Fellow, Vernalis and Professor, University of York - Juan-Miguel Jimenez, Senior Director, Head of Chemistry UK, Vertex - Malin Lemurell,Director Medicinal Chemistry, AstraZeneca - Christoph Wiessner,Chief Operating Officer / VP R&D, Asceneuron SA - Hank Wu,Head of Research IT, Biogen Idec
|
|